Patent · US Active

Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof

US11260116B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 3, 2017
Grant dateMar 1, 2022
Priority date
Expiry dateMar 6, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55572
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier. Further described are methods and use of the vaccine composition for inducing an antibody immune response and/or a cell-mediated immune response to the neoantigen, as well as methods and uses of the vaccine compositions in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.